(R)-tert-butyl 4-(5-methyl-7-oxo-6,7-dihydro-5H-cyclopenta[d]pyrimidin-4-yl)piperazine-1-carboxylate
Names and Identifiers of 1001180-21-7
CAS Number |
1001180-21-7 |
|---|---|
IUPAC Name |
tert-butyl 4-[(5R)-5-methyl-7-oxo-5,6-dihydrocyclopenta[d]pyrimidin-4-yl]piperazine-1-carboxylate |
InChI |
InChI=1S/C17H24N4O3/c1-11-9-12(22)14-13(11)15(19-10-18-14)20-5-7-21(8-6-20)16(23)24-17(2,3)4/h10-11H,5-9H2,1-4H3/t11-/m1/s1 |
InChIKey |
FYSLHZSJYXKKMC-LLVKDONJSA-N |
Canonical SMILES |
CC1CC(=O)C2=C1C(=NC=N2)N3CCN(CC3)C(=O)OC(C)(C)C |
Isomeric SMILES |
C[C@@H]1CC(=O)C2=C1C(=NC=N2)N3CCN(CC3)C(=O)OC(C)(C)C |
Physical and chemical properties of 1001180-21-7
Acidity coefficient |
3.61±0.40(Predicted) |
|---|---|
Boiling Point |
484.5±45.0°C at 760 mmHg |
Density |
1.222±0.06 g/cm3(Predicted) |
Exact Mass |
332.18500 |
LogP |
2.22650 |
Molecular Formula |
C17H24N4O3 |
Molecular Weight |
332.39700 |
PSA |
75.63000 |
Storage condition |
2-8°C |
Applications of 1001180-21-7
This compound has potential applications in medicinal chemistry due to its biological activity profile. It could serve as a lead compound for developing new pharmaceuticals targeting various diseases. Additionally, its unique structure may find applications in materials science or as a building block for synthesizing more complex organic molecules.
Interaction Studies of 1001180-21-7
Interaction studies are crucial for understanding how (R)-tert-butyl 4-(5-methyl-7-oxo-6,7-dihydro-5H-cyclopenta[d]pyrimidin-4-yl)piperazine-1-carboxylate interacts with biological targets. These studies may include:
- Binding Affinity Assays: Evaluating how well the compound binds to specific proteins or enzymes.
- Cellular Uptake Studies: Assessing how efficiently the compound enters cells and its subsequent biological effects.
- In Vivo Studies: Testing the efficacy and safety of the compound in animal models to predict human responses.
Biological Activity of 1001180-21-7
Preliminary studies suggest that compounds similar to (R)-tert-butyl 4-(5-methyl-7-oxo-6,7-dihydro-5H-cyclopenta[d]pyrimidin-4-yl)piperazine-1-carboxylate exhibit various biological activities. These may include anti-inflammatory, antimicrobial, and anticancer properties. The unique cyclopenta[d]pyrimidine structure is often associated with bioactive compounds, indicating potential therapeutic applications in treating diseases such as cancer or infections.
Physical sample testing spectrum (NMR) of 1001180-21-7